MDSCs also suppress T cell anti-tumor actions via programmed death-ligand 1 (PD-L1), arginase (Arg-1), interleukin-10 (IL-10) and transforming growth factor beta (TGF-β) (11, 12). This evidence concerns the gene TGFB1 and neoplasm.